MOERLIE, Ashwin R et al. Inpatient prescribing of dual antiplatelet therapy according to the
guidelines: a prospective intervention study. Pharmacy Pract (Granada)[online]. 2020, vol …

Coronary artery disease (CAD), including stable angina and acute coronary syndrome
(ACS), is a leading cause of death and hospitalization in Canada. 1 About 2.4 million adult …

International guidelines recommend the use of aspirin treatment immediately and
indefinitely in coronary patients. The optimal time to start and the duration of dual antiplatelet …

Introduction 'Real world'bleeding in patients exposed to different regimens of dual
antiplatelet therapy (DAPT) and triple therapy (TT, DAPT plus an anticoagulant) have a …

Long-term dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor (clopidogrel,
prasugrel, or ticagrelor) is recommended after acute coronary syndrome (ACS) to reduce the …

Background For secondary prevention of acute coronary syndrome, guidelines recommend
dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y12 receptor antagonist …

Coronary artery disease (CAD) is prevalent throughout the world, with a significant impact
on global health. There is a vast collection of data in the medical literature relating to the …

Risk-based antithrombotic strategies after percutaneous coronary intervention (PCI). Dual
antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is indicated for …

Dual antiplatelet therapy (DAPT) is recommended for patients presenting with acute
coronary syndromes and patients undergoing coronary angioplasty with drug eluting stent …

Introduction Real‐world, country‐specific studies of dual antiplatelet therapy (DAPT)
duration among survivors of acute coronary syndrome (ACS) are important for improving …